Skip to main content
Livermore
Livermore
ZHEN

Pyxis Oncology, Inc.

PYXS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001782223

In the last 90 days, Pyxis Oncology, Inc. insiders filed 0 open-market purchases and 1 sale; 76 institutions reported holding it in 13F filings for Q2 2026, worth $101.1M in total; no superinvestor holds it.

Holders of 5% or more of PYXS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Pyxis Oncology, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of PYXS
HolderLatest formStakeChangeFirst filedLatest filingFiling
GordonMD Global Investments LP13G/A12.10%10.0M shares+5.90 ppfrom 6.20%Sep 23, 20252 filingsJul 2, 2026SEC
Sullivan Lara13D/A11.21%7.54M shares+0.91 ppfrom 10.30%Oct 22, 20214 filingsApr 2, 2025SEC
Biotechnology Value Fund L P13G9.99%8.34M shares–Dec 20, 20213 filingsJul 10, 2026SEC
Laurion Capital Management LP13G/A7.72%4.80M shares–Feb 8, 20232 filingsFeb 9, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

30 Schedule 13D and 13G filings on Pyxis Oncology, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PYXS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jul 10, 20264:07 PM ETBiotechnology Value Fund L Pand 9 others13G9.99%8.34M shares–Jul 2, 2026SEC
Jul 2, 20264:10 PM ETGordonMD Global Investments LPand 3 others13G/A12.10%10.0M shares+5.90 ppfrom 6.20%Jun 30, 2026SEC
Feb 9, 202611:23 AM ETLaurion Capital Management LPand 2 others13G/A7.72%4.80M shares–Dec 31, 2025SEC
Oct 14, 20254:05 PM ETMillennium Management LLCand 2 others13G/A1.30%818.1K shares−4.40 ppfrom 5.70%Below 5%Sep 30, 2025SEC
Sep 23, 20252:02 PM ETGordonMD Global Investments LPand 3 others13G6.20%3.83M sharesNewJul 14, 2025SEC
Jul 17, 20258:12 PM ETBlackRock, Inc.13G/A1.50%926.8K shares−4.10 ppfrom 5.60%Below 5%Jun 30, 2025SEC
Jul 1, 20254:37 PM ETMillennium Management LLCand 2 others13G5.70%3.54M sharesNewJun 27, 2025SEC
May 6, 20254:17 PM ETIntegrated Core Strategies (US) LLCand 3 others13G/A4.00%2.49M shares−1.30 ppfrom 5.30%Below 5%Mar 31, 2025SEC
Apr 2, 20259:25 PM ETSullivan Lara13D/A11.21%7.54M shares+0.91 ppfrom 10.30%Mar 31, 2025SEC
Feb 14, 20254:01 PM ETRidgeback Capital Investments L.P.and 2 others13G/A0.60%359.2K shares–Below 5%Dec 31, 2024SEC
Feb 14, 20258:48 AM ETDeep Track Capital, LPand 2 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 4, 20253:45 PM ETBlackRock, Inc.13G5.60%3.34M sharesNewDec 31, 2024SEC
Dec 23, 20246:31 PM ETSullivan Lara13D/A10.30%6.62M shares–Dec 23, 2024SEC
Dec 16, 20244:04 PM ETIntegrated Core Strategies (US) LLCand 3 others13G5.30%3.16M sharesNewDec 9, 2024SEC
Mar 23, 2023Pfizer Inc13G/AOld format–––SEC
Feb 14, 2023Tang Capital Partners LP13G/AOld format–––SEC
Feb 14, 2023Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2023Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 14, 2023RTW Investments, LP13G/AOld format–––SEC
Feb 13, 2023Pfizer Inc13G/AOld format–––SEC
Feb 8, 2023Laurion Capital Management LP13GOld format–New–SEC
Nov 4, 2022Tang Capital Partners LP13GOld format–New–SEC
May 23, 2022Sullivan Lara13D/AOld format–––SEC
Feb 14, 2022Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2022RTW Investments, LP13GOld format–New–SEC
Feb 11, 2022Bayer World Investments B.V.13GOld format–New–SEC
Feb 11, 2022Pfizer Inc13GOld format–New–SEC
Dec 20, 2021Biotechnology Value Fund L P13GOld format–New–SEC
Oct 25, 2021Ra Capital Management, L.P.13GOld format–New–SEC
Oct 22, 2021Sullivan Lara13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Pyxis Oncology, Inc. shares.

No Form 144 notices for Pyxis Oncology, Inc. are on file.